Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CME Group stock | $188.65

Learn how to easily invest in CME Group stock.

CME Group Inc is a financial data & stock exchanges business based in the US. CME Group shares (CME) are listed on the NASDAQ and all prices are listed in US Dollars. CME Group employs 4,370 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in CME Group

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CME – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CME Group stock price (NASDAQ: CME)

Use our graph to track the performance of CME stocks over time.

CME Group shares at a glance

Information last updated 2021-09-17.
Latest market close$188.65
52-week range$142.32 - $219.88
50-day moving average $200.83
200-day moving average $207.80
Wall St. target price$221.47
PE ratio 35.2617
Dividend yield $3.5 (1.85%)
Earnings per share (TTM) $5.35

Buy CME Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CME Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CME Group price performance over time

Historical closes compared with the close of $188.65 from 2021-09-17

1 week (2021-09-10) -0.30%
1 month (2021-08-18) -10.35%
3 months (2021-06-18) -10.47%
6 months (2021-03-18) -8.32%
1 year (2020-09-18) 11.59%
2 years (2019-09-18) -12.73%
3 years (2018-09-18) 9.43%
5 years (2016-09-16) 72.05%

Is CME Group under- or over-valued?

Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CME Group's P/E ratio

CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, CME Group shares trade at around 35x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CME Group's PEG ratio

CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1887. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CME Group's EBITDA

CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.9 billion.

The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.

CME Group financials

Revenue TTM $4.6 billion
Operating margin TTM 53.81%
Gross profit TTM $4.9 billion
Return on assets TTM 1.05%
Return on equity TTM 7.17%
Profit margin 41.75%
Book value $74.69
Market capitalisation $67.8 billion

TTM: trailing 12 months

Shorting CME Group shares

There are currently 4.7 million CME Group shares held short by investors – that's known as CME Group's "short interest". This figure is 2.6% up from 4.6 million last month.

There are a few different ways that this level of interest in shorting CME Group shares can be evaluated.

CME Group's "short interest ratio" (SIR)

CME Group's "short interest ratio" (SIR) is the quantity of CME Group shares currently shorted divided by the average quantity of CME Group shares traded daily (recently around 1.3 million). CME Group's SIR currently stands at 3.61. In other words for every 100,000 CME Group shares traded daily on the market, roughly 3610 shares are currently held short.

However CME Group's short interest can also be evaluated against the total number of CME Group shares, or, against the total number of tradable CME Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CME Group's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CME Group shares in existence, roughly 10 shares are currently held short) or 0.0133% of the tradable shares (for every 100,000 tradable CME Group shares, roughly 13 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CME Group.

Find out more about how you can short CME Group stock.

CME Group's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CME Group.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

CME Group's total ESG risk score

Total ESG risk: 16.2

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CME Group's overall score of 16.2 (as at 12/31/2018) is excellent – landing it in it in the 10th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like CME Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

CME Group's environmental score

Environmental score: 6.41/100

CME Group's environmental score of 6.41 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

CME Group's social score

Social score: 9.64/100

CME Group's social score of 9.64 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

CME Group's governance score

Governance score: 8.65/100

CME Group's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CME Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

CME Group's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. CME Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that CME Group has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

CME Group Inc was last rated for ESG on: 2019-01-01.

Total ESG score 16.2
Total ESG percentile 9.8
Environmental score 6.41
Environmental score percentile 5
Social score 9.64
Social score percentile 5
Governance score 8.65
Governance score percentile 5
Level of controversy 1

CME Group share dividends

84%

Dividend payout ratio: 83.87% of net profits

Recently CME Group has paid out, on average, around 83.87% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.91% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 1.91% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $3.5 per share.

CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

CME Group's most recent dividend payout was on 26 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 September 2021 (the "ex-dividend date").

Have CME Group's shares ever split?

CME Group's shares were split on a 5:1 basis on 22 July 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for CME Group shares which in turn could have impacted CME Group's share price.

CME Group share price volatility

Over the last 12 months, CME Group's shares have ranged in value from as little as $142.3181 up to $219.8765. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.4329. This would suggest that CME Group's shares are less volatile than average (for this exchange).

CME Group overview

CME Group Inc. , together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.

Frequently asked questions

What percentage of CME Group is owned by insiders or institutions?
Currently 0.436% of CME Group shares are held by insiders and 88.064% by institutions.
How many people work for CME Group?
Latest data suggests 4,370 work at CME Group.
When does the fiscal year end for CME Group?
CME Group's fiscal year ends in December.
Where is CME Group based?
CME Group's address is: 20 South Wacker Drive, Chicago, IL, United States, 60606
What is CME Group's ISIN number?
CME Group's international securities identification number is: US12572Q1058
What is CME Group's CUSIP number?
CME Group's Committee on Uniform Securities Identification Procedures number is: 12572Q105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site